Pillstats
Rx only · Suspension, Extended Release · Oral

Methylphenidate Hydrochloride

Brands: Quillivant Xr · Methylphenidate Hydrochloride

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US4 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN06BA04
RxCUI (US)6901
US makers1 labelers
Packages4
DEA / ScheduleCII

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.868$1.74$2.60$3.47Dec 2025Apr 2026Jul 2026
$3.016
Latest avg · Jul 22, 2026
+0%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

35K71K106K142K2025 Q12025 Q22025 Q32025 Q42026 Q1
118K
Rx · 2026 Q1
19.1M
Units dispensed
+3%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
NextWave Pharmaceuticals, Incunknown4SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.